Ho SYA, Tay KV. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives. World J Gastrointest Surg. 2023;15(10):2280–93.

Article  PubMed  PubMed Central  Google Scholar 

Irino T, Sano T, Hiki N, Ohashi M, Nunobe S, Kumagai K, et al. Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc. 2018;32(1):268–75.

Article  PubMed  Google Scholar 

Borgstein ABJ, van Berge Henegouwen MI, Lameris W, Eshuis WJ, Gisbertz SS, Dutch Upper GI Cancer Audit. Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent. Eur J Surg Oncol. 2021;47(6):1441–8.

Article  PubMed  Google Scholar 

Sakamoto E, Ramos MFKP, Pereira MA, Dias AR, Ribeiro Junior U, Zilberstein B, et al. staging laparoscopy is still a valuable tool for optimal gastric cancer management. Arq Bras Cir Dig. 2023;35:e1700.

Article  PubMed  PubMed Central  Google Scholar 

Young S, Ou R, Dehal A, O’Connor VV, DiFronzo LA. Peritoneal lavage cytology following neoadjuvant chemotherapy for gastric adenocarcinoma: low yield in detecting peritoneal metastases. Am Surg. 2022;88(6):1084–9.

Article  PubMed  Google Scholar 

Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234–47.

Article  CAS  PubMed  Google Scholar 

Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24(11):1181–95.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, et al. International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). Ann Gastroenterol Surg. 2021;6(2):227–40.

Article  PubMed  PubMed Central  Google Scholar 

Yamaguchi T, Takashima A, Nagashima K, Terashima M, Aizawa M, Ohashi M, et al. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study. Gastric Cancer. 2021;24(3):701–9.

Article  CAS  PubMed  Google Scholar 

Yasufuku I, Nunobe S, Ida S, Kumagai K, Ohashi M, Hiki N, et al. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy. Gastric Cancer. 2020;23(2):319–27.

Article  CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely-available easy-to-use software “EZR” (Easy R) for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.

Article  CAS  PubMed  Google Scholar 

Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, et al. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol. 2013;20(2):548–54.

Article  PubMed  Google Scholar 

Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, et al. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol. 2018;118(1):61–7.

Article  PubMed  PubMed Central  Google Scholar 

Ushimaru Y, Fujiwara Y, Kishi K, Sugimura K, Omori T, Moon JH, et al. Prognostic significance of basing treatment strategy on the results of photodynamic diagnosis in advanced gastric cancer. Ann Surg Oncol. 2017;24(4):983–9.

Article  PubMed  Google Scholar 

van Hootegem SJM, Guchelaar NAD, van der Sluis K, Triemstra L, Mönig SP, Rawicz-Pruszyński K, et al. Staging laparoscopy for gastric cancer: European consensus. Br J Surg. 2025; 112(9): znaf144.

Al-Batran SE, Goetze TO, Mueller DW, Vogel A, Winkler M, Lorenzen S, et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer. 2017; 17(1): 893.

Al-Batran SE, Lorenzen S, Riera J, Caca K, Mueller C, Stange DE, et al. Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: the IKF-575/RENAISSANCE phase III trial. J Clin Oncol. 2024. https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA4001.

Article  PubMed  PubMed Central  Google Scholar 

Kita R, Yasufuku I, Takahashi N, Mizusawa J, Sano Y, Fukuda H, et al. Randomized controlled phase III study comparing chemotherapy alone versus conversion surgery after a remarkable response to chemotherapy in patients with initially unresectable cStage IVB or pStage IV gastric cancer (JCOG2301, Conversion study). Jpn J Clin Oncol. 2025;55(3):304–10.

Article  PubMed  Google Scholar